A US-based ganja research firm said Jamaica is missing out on investments in the sector because of how long it takes the Cannabis Licensing Authority (CLA) to issue licences for legitimate businesses.

Medical research firm MMJ International Holdings (MMJ) said the cumbersome process has forced it to turn to Uruguay-based Global Cannabis Production (GCP) to import raw materials and finished products so as to support the clinical trials and drug development that it was initially seeking to do in Jamaica. It had sought to collaborate with the Manchester-based Northern Caribbean University (NCU) on the project to produce pharmaceuticals from ganja.

“NCU and MMJ had started this process in 2016,” Duane Boise, CEO of MMJ, lamented as he pointed out that NCU has been unable to receive the necessary approval and licensing for the operation. “It is

 

https://www.jamaicaobserver.com/business/missed-opportunities/